Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sedona Sweeney

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
BMJ Open|October 11, 2020
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudySedona Sweeney, Gabriela Gomez, Nichola Kitson, et al.
Plos Medicine|May 3, 2024
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysisLyndon P James, Fayette Klaassen, Sedona Sweeney, et al.
Plos One|May 14, 2015
Scaling Down to Scale Up: A Health Economic Analysis of Integrating Point-of-Care Syphilis Testing into Antenatal Care in Zambia during Pilot and National Rollout ImplementationKatharine D Shelley, Éimhín M Ansbro, Alexander Tshaka Ncube, et al.
Plos One|May 2, 2015
The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource SettingsCarol Dayo Obure, Sedona Sweeney, Vanessa Darsamo, et al.
Pharmacoeconomics|May 29, 2020
Correction to: A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Optimizing TB policies using the global TB portfolio model: an economic analysisSrinath Satyanarayana, Sandip Mandal, Finn McQuaid, et al.
Pharmacoeconomics|May 5, 2020
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
Trials|July 27, 2018
Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trialJames J Lewis, Xiaoqiu Liu, Zhiying Zhang, et al.
BMJ Global Health|May 27, 2021
Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countriesSedona Sweeney, Theo Prudencio Juhani Capeding, Rosalind Eggo, et al.
BMJ Public Health|March 11, 2026
Cost-effectiveness of cancer interventions in Rwanda: literature review and expert elicitation for health benefits package designCassandra Nemzoff, Andres Madriz-Montero, Inga Mumukunde, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
BMJ Open|October 11, 2020
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudySedona Sweeney, Gabriela Gomez, Nichola Kitson, et al.
Plos Medicine|May 3, 2024
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysisLyndon P James, Fayette Klaassen, Sedona Sweeney, et al.
Plos One|May 14, 2015
Scaling Down to Scale Up: A Health Economic Analysis of Integrating Point-of-Care Syphilis Testing into Antenatal Care in Zambia during Pilot and National Rollout ImplementationKatharine D Shelley, Éimhín M Ansbro, Alexander Tshaka Ncube, et al.
Plos One|May 2, 2015
The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource SettingsCarol Dayo Obure, Sedona Sweeney, Vanessa Darsamo, et al.
Pharmacoeconomics|May 29, 2020
Correction to: A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Optimizing TB policies using the global TB portfolio model: an economic analysisSrinath Satyanarayana, Sandip Mandal, Finn McQuaid, et al.
Pharmacoeconomics|May 5, 2020
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost TypologyLucy Cunnama, Gabriela B Gomez, Mariana Siapka, et al.
Trials|July 27, 2018
Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trialJames J Lewis, Xiaoqiu Liu, Zhiying Zhang, et al.
BMJ Global Health|May 27, 2021
Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countriesSedona Sweeney, Theo Prudencio Juhani Capeding, Rosalind Eggo, et al.
BMJ Public Health|March 11, 2026
Cost-effectiveness of cancer interventions in Rwanda: literature review and expert elicitation for health benefits package designCassandra Nemzoff, Andres Madriz-Montero, Inga Mumukunde, et al.
Pageof 6